Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Conjugated antibodies against LY75 for the treatment of cancer

Conjugated antibodies against LY75 for the treatment of cancer

US Patent 10081682 · Granted Sep 25, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2025
Genetically engineered T cells having improved persistence in culture2025
T-cells expressing anti-LIV1 chimeric antigen receptor2025
Methods and compositions for treating cancer2025
Anti-PTK7 immune cell cancer therapy2024
Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related cond2024
Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK2024
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use the2023
CRTAM antibodies and methods of treating cancer2023
Methods and compositions for treating cancer2023
Materials and methods for engineering cells and uses thereof in immuno-oncology2023
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2023